🇺🇸 FDA
Patent

US 6455509

Dengue nucleic acid vaccines that induce neutralizing antibodies

expired A61KA61K2039/53

Quick answer

US patent 6455509 (Dengue nucleic acid vaccines that induce neutralizing antibodies) held by United States of America as represented by the Secretary of the Air Force expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/53